Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785) (Q74623160)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 1999

Language	Label	Description	Also known as
English	Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)	scientific article published on 01 April 1999

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

ChEBI release 2020-05-28

Douglas B. Kitchen

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

C M Discafani

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M L Carroll

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M B Floyd

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

I J Hollander

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Z Husain

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

B D Johnson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M K May

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M S Malo

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A A Minnick

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Nilakantan

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Shen

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Y F Wang

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A Wissner

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

L M Greenberger

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Biochemical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

57

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

917-925

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

The type 1 (EGFR-related) family of growth factor receptors and their ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Signaling through scaffold, anchoring, and adaptor proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Receptor blockade with monoclonal antibodies as anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Epidermal‐Growth‐Factor‐Dependent Activation of the Src‐Family Kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Crystal Structure of the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(98)00356-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74623160&oldid=2083399260"